MENU
+Compare
VCYT
Stock ticker: NASDAQ
AS OF
Jan 21 closing price
Price
$43.60
Change
+$3.02 (+7.44%)
Capitalization
1.66B

VCYT Veracyte Forecast, Technical & Fundamental Analysis

a company that discovers, develops and commercializes molecular diagnostic solutions

VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for VCYT with price predictions
Jan 08, 2025

VCYT's Stochastic Oscillator remains in overbought zone for 2 days

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VCYT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 03, 2025. You may want to consider a long position or call options on VCYT as a result. In of 105 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VCYT just turned positive on January 08, 2025. Looking at past instances where VCYT's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VCYT advanced for three days, in of 308 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VCYT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.556) is normal, around the industry mean (23.424). P/E Ratio (0.000) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (4.354) is also within normal values, averaging (41.167).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VCYT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

VCYT is expected to report earnings to fall 70.12% to 9 cents per share on March 03

Veracyte VCYT Stock Earnings Reports
Q4'24
Est.
$0.10
Q3'24
Beat
by $0.30
Q2'24
Beat
by $0.08
Q1'24
Beat
by $0.14
Q4'23
Missed
by $0.30
The last earnings report on November 06 showed earnings per share of 33 cents, beating the estimate of 2 cents. With 666.51K shares outstanding, the current market capitalization sits at 1.66B.
A.I. Advisor
published General Information

General Information

a company that discovers, develops and commercializes molecular diagnostic solutions

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
6000 Shoreline Court
Phone
+1 650 243-6300
Employees
815
Web
https://www.veracyte.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TROSX12.930.22
+1.73%
T. Rowe Price Overseas Stock
PICOX39.460.62
+1.60%
Putnam International Capital Opp R6
LMRNX32.060.27
+0.85%
1919 Socially Responsive Balanced I
GABTX21.63N/A
N/A
Gabelli Global Content & Connect AAA
GIRMX22.92N/A
N/A
Goldman Sachs Emerging Markets Eq Inv

VCYT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been closely correlated with NTLA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if VCYT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
+7.44%
NTLA - VCYT
69%
Closely correlated
+4.63%
VCEL - VCYT
60%
Loosely correlated
+0.83%
AXON - VCYT
58%
Loosely correlated
+1.97%
DNA - VCYT
57%
Loosely correlated
+6.93%
ABCL - VCYT
55%
Loosely correlated
+3.03%
More